Status:

COMPLETED

A Proximity-incentive Strategy for Cervical Cancer Screening

Lead Sponsor:

University Hospital, Montpellier

Collaborating Sponsors:

Paul Valérie University Montpellier

Regional Center for Cancer Screening (CRCDC) - Region of Occitanie - Department of Herault

Conditions:

Cervical Cancer

Uterine Cervical Disease

Eligibility:

FEMALE

50-65 years

Phase:

NA

Brief Summary

In France, cervical cancer screening is based on a cervical smear for women aged 25 to 30 years and on High Risk- HPV (HR-HPV) testing for women aged 30 to 65 years. One of the main concerns in France...

Detailed Description

Scientific context : In France, cervical cancer screening is based on a cervical smear every three years for women aged 25 to 30 years, and on a High-Risk HPV (HR-HPV) detection test every five years...

Eligibility Criteria

Inclusion

  • Asymptomatic women 50 to 65 years old (50 and 65 years included)
  • With no cervical smear (or gynecologic examination) or HPV test for at least 3 years (≥ 3 years)
  • Able to understand the study and provide voluntarily a written consent to participate
  • Able to understand and answer the questions of the study questionnaire by themselves or with the help of a self-chosen third party
  • Beneficiary of social security insurance

Exclusion

  • Women deprived of their liberty, protected adults or vulnerable persons
  • Known cervical lesion or known HPV status
  • History of hysterectomy
  • History of cervix pathology (conization, laser treatment of the cervix)
  • History of cervical cancer
  • Known immune-depression

Key Trial Info

Start Date :

September 16 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 25 2024

Estimated Enrollment :

656 Patients enrolled

Trial Details

Trial ID

NCT04716127

Start Date

September 16 2021

End Date

July 25 2024

Last Update

July 30 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Arnaud de Villeneuve Hospital, clinical trials Department

Montpellier, Herault, France, 34295

2

Mammobile Hérault

Montpellier, France